Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Current Pharmaceutical Design
|
October 8, 2003
ADP receptors--targets for developing antithrombotic agents
Satya P Kunapuli, Zhongren Ding, Robert T Dorsam, et al.
Blood
|
May 15, 2004
Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses
Haripriya Shankar, Swaminathan Murugappan, Soochong Kim, et al.
Platelets
|
March 4, 2015
DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase
Jianqin Ye, Lili Zhai, Shenghui Zhang, et al.
Plos One
|
July 21, 2012
BF066, a novel dual target antiplatelet agent without significant bleeding
ChangE Pan, Xunbin Wei, Jianqin Ye, et al.
Journal of Medical Virology
|
November 27, 2019
Platelet activation during chronic hepatitis B infection exacerbates liver inflammation and promotes fibrosis
Qirong Jiang, Richeng Mao, Jingwen Wu, et al.
Thrombosis Research
|
April 26, 2024
WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor
Chen Cao, Qingyuan Yang, Xiaoshuang Xia, et al.
Stem Cell Research
|
February 2, 2021
An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human
Yangyang Liu, Xiaowei Li, Wanrong Fu, et al.
Stem Cell Research
|
December 31, 2020
Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual
Wanrong Fu, Mengyu Wang, Yangyang Liu, et al.
Thrombosis Research
|
August 1, 2014
Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory
Lei Liu, Jian Li, Yan Zhang, et al.
Stem Cell Research
|
December 20, 2021
Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation
Yiming Dong, Xiaowei Li, Wanrong Fu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Current Pharmaceutical Design
|
October 8, 2003
ADP receptors--targets for developing antithrombotic agents
Satya P Kunapuli, Zhongren Ding, Robert T Dorsam, et al.
Blood
|
May 15, 2004
Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses
Haripriya Shankar, Swaminathan Murugappan, Soochong Kim, et al.
Platelets
|
March 4, 2015
DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase
Jianqin Ye, Lili Zhai, Shenghui Zhang, et al.
Plos One
|
July 21, 2012
BF066, a novel dual target antiplatelet agent without significant bleeding
ChangE Pan, Xunbin Wei, Jianqin Ye, et al.
Journal of Medical Virology
|
November 27, 2019
Platelet activation during chronic hepatitis B infection exacerbates liver inflammation and promotes fibrosis
Qirong Jiang, Richeng Mao, Jingwen Wu, et al.
Thrombosis Research
|
April 26, 2024
WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor
Chen Cao, Qingyuan Yang, Xiaoshuang Xia, et al.
Stem Cell Research
|
February 2, 2021
An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human
Yangyang Liu, Xiaowei Li, Wanrong Fu, et al.
Stem Cell Research
|
December 31, 2020
Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual
Wanrong Fu, Mengyu Wang, Yangyang Liu, et al.
Thrombosis Research
|
August 1, 2014
Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory
Lei Liu, Jian Li, Yan Zhang, et al.
Stem Cell Research
|
December 20, 2021
Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation
Yiming Dong, Xiaowei Li, Wanrong Fu, et al.
Page
of 5